Maxcyte (MXCT) Inventory (2020 - 2026)

Maxcyte (MXCT) has 7 years of Inventory data on file, last reported at $7.6 million in Q1 2026.

• On a quarterly basis, Inventory fell 7.77% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 7.77% decrease from a year earlier, with the FY2025 full-year figure at $7.5 million, down 15.34% from the prior year.
• Inventory for Q1 2026 stood at $7.6 million, up from $7.5 million in the prior quarter.
• Over the last five years, Inventory for MXCT reached as high as $12.5 million in Q3 2023 and fell as low as $6.6 million in Q1 2022.
• Historically, Inventory has averaged $9.3 million across 5 years, with a median of $8.6 million in 2022.
• Across the five-year window, Inventory soared 90.71% in 2022 and plunged 30.82% in 2025, its largest moves.
• Year by year, Inventory stood at $8.6 million in 2022, then jumped by 42.51% to $12.2 million in 2023, then fell by 27.11% to $8.9 million in 2024, then decreased by 15.34% to $7.5 million in 2025, then advanced by 1.11% to $7.6 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $7.6 million in Q1 2026, $7.5 million in Q4 2025, and $7.6 million in Q3 2025.